Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304607 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ruyi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Axin Protein, Carcinoma, Hepatocellular, Liver Neoplasms, CRISPR-Cas Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Government Scholarship.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is a highly aggressive liver cancer with significant morbidity and mortality rates. AXIN1 is one of the top-mutated genes in HCC, but the mechanism by which AXIN1 mutations contribute to HCC development remains unclear.
Methods
In this study, we utilized CRISPR/Cas9 genome editing to repair AXIN1-truncated mutations in five HCC cell lines.
Results
For each cell line we successfully obtained 2–4 correctly repaired clones, which all show reduced β-catenin signaling accompanied with reduced cell viability and colony formation. Although exposure of repaired clones to Wnt3A-conditioned medium restored β-catenin signaling, it did not or only partially recover their growth characteristics, indicating the involvement of additional mechanisms. Through RNA-sequencing analysis, we explored the gene expression patterns associated with repaired AXIN1 clones. Except for some highly-responsive β-catenin target genes, no consistent alteration in gene/pathway expression was observed. This observation also applies to the Notch and YAP/TAZ-Hippo signaling pathways, which have been associated with AXIN1-mutant HCCs previously. The AXIN1-repaired clones also cannot confirm a recent observation that AXIN1 is directly linked to YAP/TAZ protein stability and signaling.
Conclusions
Our study provides insights into the effects of repairing AXIN1 mutations on β-catenin signaling, cell viability, and colony formation in HCC cell lines. However, further investigations are necessary to understand the complex mechanisms underlying HCC development associated with AXIN1 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
- Yunnan Key Laboratory of Chiral Functional Substance Research and Application, School of Chemistry & Environment, Yunnan Minzu University, Kunming, China.
- Erasmus Center for Biomics, Erasmus University Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Wilfred F J van Ijcken, Maikel P Peppelenbosch, Ron Smits
Förderung
- Chinese Government Scholarship
Zitieren
APA
Zhang, R., Li, S., Schippers, K., Eimers, B., Niu, J., Hornung, B. V. H., van den Hout, M. C. G. N., van Ijcken, W. F. J., Peppelenbosch, M. P., & Smits, R. (2024). Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines. PLOS ONE. https://doi.org/10.1371/journal.pone.0304607
Vancouver
Zhang R, Li S, Schippers K, Eimers B, Niu J, Hornung BVH, et al. Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines. PLOS ONE. 2024. doi:10.1371/journal.pone.0304607
BibTeX
@article{Zhang2024,
author = {Zhang, Ruyi and Li, Shanshan and Schippers, Kelly and Eimers, Boaz and Niu, Jiahui and Hornung, Bastian V H and van den Hout, Mirjam C G N and van Ijcken, Wilfred F J and Peppelenbosch, Maikel P and Smits, Ron},
title = {Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304607}
}
EUVIMED